havas glp-1 New Unit Focused On Opportunities Posed By Drugs 06/18/2024 Brian Robinson on GLP-1 consultancy

It showed: Average total weight loss : 28.3% TBW with surgery vs

Expected outcomes based on trial data: Average weight loss of 24.2% at 48 weeks (phase 2) Average weight loss of 28.7% at 68 weeks (phase 3, TRIUMPH-4) 100% of participants achieved 5% or greater weight loss 93% achieved 10% or greater 83% achieved 15% or greater Moderate weight loss protocol (8mg target) For researchers who want significant weight loss but have a lower tolerance for side effects, stopping the escalation at 8mg is a validated approach

doi:10.1161/CIRCULATIONAHA.111.041418 70

For Wegovy and Ozempic (weekly injections): If you miss a dose and its been less than 5 days since your missed dose, take it as soon as you remember

Complaint 3: Cost of the Medvi 3-Month Plan & Ongoing Pricing Cost is a common theme in Medvi complaints specifically, patients who did not anticipate the cumulative cost of the Medvi 3-month plan or subsequent monthly prescriptions